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Previewsand nature of IgA responses, thereby
affecting the host-mediated selection of
microbial communities in the gut. Accord-
ingly, T-MyD88/mice display increased
susceptibility to colitis. The disease pre-
disposition of T-MyD88/ mice could
be shown to be due to themicrobiota dys-
biosis, because disease severity was
significantly decreased after transfer of
fecal microbiota from WT mice. This
observation is consistent with a recent
report showing that IgA coats colitogenic
members of the microbiota and maintains
immune homeostasis (Palm et al., 2014). It
is noteworthy that Kubinak et al. further
demonstrate a significant positive corre-
lation between the relative abundance of
GC B cells and the diversity of the
mucosal bacterial community. Therefore,
a stronger GC and IgA response pro-
motes microbiota diversity, presumably
by exploiting targeted bacteria and
creating a habitable niche for rare bacte-
rial species (Figure 1).
Several genetically modified mice with
defects in the production of IgA in the
gut have been used to explore the role
of IgA in mucosal immune protection.
T-MyD88/ mice provide a valuable
opportunity to understand the previously146 Cell Host & Microbe 17, February 11, 201unexplored role of high-affinity micro-
biota-specific IgA driven by the micro-
biota-induced TFH cells in selective
control of the mucosa-associated com-
munity. It remains unknown where CD4+
T cells encounter TLR ligands, how TLR
signaling in CD4+ T cells leads to TFH cell
development, and why IgA selectively
targets mucosa-associated members.
Because most of the IgA induced by TFH
cells is specific for microbiota antigens
(Kubinak et al., 2015; Kawamoto et al.,
2014; Palm et al., 2014), TFH cells gener-
ated by the microbiota are also likely to
be specific for microbiota antigens.
Therefore, dendritic cells (DCs) are likely
to play a role in skewing the initial commit-
ment of CD4+ T cells toward the TFH sub-
set. In this context, it has been shown that
goblet cells deliver luminal antigen to
CD103+ DCs (McDole et al., 2012) and
that CD103+ DCs patrol the epithelium
and capture bacteria attaching to its sur-
face (Farache et al., 2013). Therefore,
DCs localizing to the epithelial layer may
sense and capture the mucosa-associ-
ated commensals to skew the TCR reper-
toire and the differentiation of CD4+ T cells
toward the TFH subset. In any case, the
finding by Kubinak et al. can be used to5 ª2015 Elsevier Inc.tailor therapies; for example, oral adminis-
tration of a mixture of microbiota-specific
high-affinity IgAs can be an effective ther-
apy to treat microbiota-driven disease by
restoring microbiota diversity.
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The ability of the gut epithelium to defend against pathogens while tolerating harmless commensal organ-
isms remains an important puzzle. In this issue of Cell Host & Microbe, Lee et al. (2015) reveal how path-
ogen-secreted uracil acts at two steps to induce ROS via the Hedgehog pathway.Epithelial barriers represent essential
lines of defense against tissue invasion
by bacterial and viral pathogens. For a
sterile barrier such as the alveolar epithe-
lium of the lung, this challenge boils down
to keeping the pathogens and their effec-
tors out. In the setting of a diverse naturalecosystem in the gut, the problem is
significantly more complicated. Although
pathogenic species must be prevented
from invading the host or causing local
tissue damage, beneficial or symbiotic
bacteria comprising the commensal mi-
crobiota require tolerance. Thus, boththe innate and adaptive (in vertebrates)
immune systems must somehow distin-
guish friend from foe and respond
accordingly.
Drosophila has emerged as an impor-
tant model genetic system for analyzing
gut homeostasis. The Drosophila gut
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Figure 1. Dual Activities of Uracil in Hedgehog-Mediated Defense against Enteropathogenic
Bacteria
Pathogenic (but not commensal) bacteria liberate uracil, which acts via two unknown receptors (U-RX and
U-RY) to induce ROS production to combat infection. Activation of U-RX induces Hedgehog (Hh) expres-
sion either via the known effectors MEKK1/ATF2 (which induce DOUX expression) or by an alternative
pathway. Hh is then secreted from cells and binds to Patched (PTC) to relieve inhibition of Smoothened
(SMO) signaling, which in turn inhibits the activity of protein kinase A (PKA) to activate target genes
including Cad99C via the transcriptional effector Ci (analogous to Gli proteins in mammals). Activation
of the second uracil receptor, U-RY, leads to internalization of the receptor complex into signaling
endosomes (SE), clustering of Cad99C, activation of PLCb/PKC signaling, Ca2+ release from the endo-
plasmic reticulum (ER), and DUOX-mediated ROS synthesis to kill the pathogenic bacteria.
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Previewshas a high degree of morphologic and ul-
trastructural similarity to the vertebrate
intestine, including the presence of func-
tionally distinct domains analogous to
the vertebrate small intestine (midgut)
and colon (hindgut), as well as functional
similarities such as a capacity for stem
cell renewal and the generation of reac-
tive oxygen species (ROS) in response
to damage (for review, see Buchon
et al., 2013; Kim and Lee, 2014). An
important advance in understanding in-
testinal immune homeostasis was made
when Lee and colleagues discovered
that uracil alerts the Drosophila innate
immune system to the presence of
enteropathogenic bacteria (Lee et al.,
2013), triggering production of antibacte-
rial ROS. In that study, the host path-
way(s) mediating the uracil signaling
response for ROS production and path-
ogen neutralization were unknown. In
this issue, Lee et al. now identify the
Hedgehog (Hh) pathway as a primary
target and effector of uracil (Lee et al.,
2015) (Figure 1).To identify the mechanism of uracil-
mediated ROS activation, the authors
performed a comparative transcriptional
analysis of uracil-treated versus control
intestinal tissue. The Hh signaling path-
way scored as the top hit. Indeed, expres-
sion of the Hh ligand itself was strongly
upregulated in response to uracil treat-
ment, consistent with results of a prior
study showing increased Hh expression
upon enteric infection (Buchon et al.,
2009). Effects of uracil treatment (e.g.,
ROS production) are blocked by inhibition
of Hh signal transduction, while experi-
mental over-activation of the Hh pathway
inducedROS even in the absence of uracil
treatment.
A critical conclusion of this detailed
multipronged analysis is that uracil has
two distinct yet synergistic effects that
impact epithelial defense. First, uracil
induces expression of the Hh ligand via
an unknown receptor (Receptor X) to acti-
vate Hh signaling and expression of the
target gene Cad99, a cadherin family
member localized in the plasma mem-Cell Host & Microbe 17,brane. Uracil signaling through a second
receptor (Receptor Y, a suspected G pro-
tein-coupled receptor) leads to Cad99
clustering, PLCb/PKC activation, induc-
tion of Ca2+ release from endoplasmic re-
ticulum (ER) stores, and stimulation of the
cell surface DUOX enzyme to produce
ROS. The dual action of uracil in this pro-
cess was elegantly demonstrated when
constitutive activation of Hh signaling
induced ROS production in convention-
ally reared flies (exposed to uracil-pro-
ducing bacteria), but not in flies raised un-
der germ-free conditions. Inhibition of Hh
signaling during infection was associated
with high host mortality, highlighting the
essential role of the pathway. Overex-
pression of the critical Cad99C moiety in
a Hh-deficient background restored for-
mation of the signaling endosome and,
consequently, Ca2+-dependent activation
of ROS production and resistance to
infection.
These discoveries raise several inter-
esting questions for future study. Molecu-
lar identification of the two distinct recep-
tors that interact with uracil is of primary
interest: Receptor X, involved in inducing
Hh expression (and thereby expression
of Cad99C), and Receptor Y, involved in
transducing Ca2+-activated DUOX activ-
ity via the Rab7+ signaling endosome.
The authors suspect that MEKK1, which
is required for ATF2-dependent induction
of DUOX gene expression (Ha et al.,
2009a, 2009b), lies downstream of Re-
ceptor X. In the case of signal transduc-
tion via receptor Y, one must both tease
apart how uracil-dependent receptor acti-
vation leads to clustering of Cad99C and
how this stimulates PLCb/PKC activity.
Furthermore, whether Hh expression is
induced in the same cells that respond
to the ligand or in a distinct cell population
remains to be determined. Peptidoglycan,
shown by others to also induce Hh
signaling (but not Cad99C-dependent en-
dosomal signaling and DUOX activation),
could activate Hh expression by the
same or a different pathway. The activa-
tion of Hh expression may be linked
to other known roles of this pathway
(or Ca2+ signaling) in gut homeostasis,
including regulation of stem cell prolifera-
tion in the Drosophila hindgut (Takashima
et al., 2008), an organ that shares similar-
ities in organization with the mammalian
crypt-villus axis (Pitsouli and Perrimon,
2008).February 11, 2015 ª2015 Elsevier Inc. 147
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PreviewsIt remains to be seen whether ROS
production can be compartmentalized
to bias killing of pathogenic bacteria
and sparing commensal microflora, or
whether the inflammatory process is
indiscriminate with regard to bacterial
class. A recent study found that
commensal lactobacilli stimulate stem
cell proliferation via ROS produced by
another synthetic enzyme, Nox, in both
flies and mammals (Jones et al.,
2013). Since lactobacilli do not induce
DUOX via activation of the signaling en-
dosome, it is intriguing how ROS pro-
duced via these two different pathways
can lead to alternative cellular re-
sponses. Another remaining puzzle is
how or why uracil secretion represents
an accurate indicator of potentially
pathogenic species (Lee et al., 2013),
and what mechanisms might be
responsible for suppressing uracil148 Cell Host & Microbe 17, February 11, 201secretion in different commensal spe-
cies (e.g., altered synthesis, transport,
metabolism, or sequestration). Certainly
additional pathogen signals beyond ura-
cil may feed into the identified path-
ways, and/or alternative signals pro-
duced by commensal bacteria could
dampen immune responses at baseline
to defend the gut epithelium against
ROS damage. These may be productive
avenues to build upon the key ad-
vances of this work and to investigate
in diverse model systems including
mammals.REFERENCES
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In this issue of Cell Host & Microbe, Huang et al. (2015) and Guo et al. (2015), along with recent work byWang
et al. (2014), reveal that HSV ribonucleotide reductase has opposing activities in either inducing or preventing
necroptosis, depending on the host species. This evolutionary twist underscores the importance of selective
pressure in virus-host relationships.The induction of cell death in response to
viral pathogens represents a powerful
component of the host defense machin-
ery. It is of no surprise that viruses have
evolved potent counterdefense mecha-
nisms. The best-studied cell death
pathway is apoptosis, characterized by
its dependence on caspase activation.
Apoptosis has long been recognized as
an important antiviral mechanism, by
efficiently and ‘‘quietly’’ clearing dying
cells. Multicellular organisms prevent the
spread of viral infections by inducing
apoptosis, and viruses, in turn, have
evolved mechanisms to block caspaseactivation, thereby preventing apoptosis
(reviewed in Chan et al., 2014). In
response, mammalian hosts have
evolved a backup mechanism, pro-
grammed necrosis or necroptosis, to kill
cells and limit viral spread. This defense
and counterdefense tug of war reflects a
robust evolutionary arms race between
hosts and their pathogens that continues
to escalate.
Apoptosis and necroptosis pathways
are interconnected, and the balance
between the two is tightly regulated.
Stimulation of the death receptors in the
tumor necrosis factor (TNF) family leadsto activation of apoptosis via caspase-8,
which also prevents necroptosis by
cleaving the adaptor proteins receptor-
interacting kinase 1 (RIP1) and RIP3.
Under conditions in which caspase-8 is
inhibited, RIP1 can engage with its part-
ner RIP3 through their RIP homotypic
interaction motifs (RHIMs), forming a
multiprotein complex termed the ne-
crosome. Here, RIP3 kinase is acti-
vated, resulting in the phosphorylation
of the mixed lineage kinase domain-
like (MLKL) protein, leading to MLKL
complex formation and eventual mem-
brane disruption (Figure 1A) (reviewed
